Laboratory assessment of the risks of malignant neoplasms of the mammary gland and ovaries
In most cases, oncological diseases are hereditary: for breast cancer – 5–10%, and for ovarian cancer – 10–17%, and associated with the support of mutations in certain genes derived from one of the parents. Genetic testing can identify predisposition to hereditary forms of cancer and direct efforts...
Main Authors: | А. В. Шумицький, О. А. Бурка, І. В. Сідорова |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House TRILIST
2018-06-01
|
Series: | Репродуктивная эндокринология |
Subjects: | |
Online Access: | http://reproduct-endo.com/article/view/133775 |
Similar Items
-
GENETIC RISK MARKERS FOR SUPERFICIAL AND INVASIVE BLADDER CANCER
by: V. N. Pavlov, et al.
Published: (2014-07-01) -
GENETIC RISK MARKERS FOR SUPERFICIAL AND INVASIVE BLADDER CANCER
by: V. N. Pavlov, et al.
Published: (2014-07-01) -
POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCER
by: I. A. KOROLEVA, et al.
Published: (2017-06-01) -
Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series
by: Miriana d’Alessandro, et al.
Published: (2021-01-01) -
Morphological and immunohistochemical peculiarities of oncomarkers in placental barrier
by: T.D. Zadorozhnaya, et al.
Published: (2012-04-01)